Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF COMPONENTS OF LIABILITIES AND REVENUE CLASSIFIED AS DISCONTINUED OPERATIONS (Details)

v3.22.2.2
SCHEDULE OF COMPONENTS OF LIABILITIES AND REVENUE CLASSIFIED AS DISCONTINUED OPERATIONS (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Current assets of discontinued operations $ 28   $ 28   $ 3,093
Current liabilities of discontinued operations 858   858   3,157
Income tax (benefit) expense (11) $ (714) 24 $ (684)  
Discontinued Operations, Disposed of by Sale [Member]          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Accounts receivable, net     1,486
Other 28   28   1,607
Current assets of discontinued operations 28   28   3,093
Property and equipment, net     6,032
Other intangible assets, net     5,155
Goodwill     8,433
Other     2,767
Long-term assets of discontinued operations     22,387
Total assets 28   28   25,480
Accounts payable     1,320
Accrued salary and bonus 92   92   335
Other [1] 766   766   1,502
Current liabilities of discontinued operations 858   858   3,157
Operating lease liabilities, net of current portion     2,634
Other     71
Long-term liabilities of discontinued operations     2,705
Total liabilities 858   858   $ 5,862
Revenue, net 1,267 1,415 5,678 6,455  
Loss from discontinued operations (13,012) (2,180) (15,888) (5,744)  
Gain (loss) on sale of Pharma Solutions  
Income tax (benefit) expense (58) 62 48 175  
Loss from discontinued operations, net of tax $ (12,954) $ (2,242) $ (15,936) $ (5,919)  
[1] Includes $766 of liabilities related to the former Commercial Services business unit.